13 days ago • Posted by Jasper Lawler
Vaccitech, the biotech behind the AstraZeneca vaccine plans New York IPO
Vaccitech just landed a blow on UK Prime Minister Boris Johnson's vision of the UK as a biotech startup hub around Oxford and Cambridge. The firm is eyeing a listing in New York.
Vaccitech is taking advantage of investor appetite for scientific innovation highlighted by the pandemic, with 2020 a booming year for biotech IPOs. Shares in vaccine maker Moderna have soared almost 300 per cent and shares in BioNTech, which partnered with Pfizer to make a Covid-19 vaccine, have climbed more than 120 per cent in the past year.
via @FT The Financial Times